1-6 of 6
Steliana Calin
Close
Sort by
Journal Articles

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

Alessandra Ferrajoli, Tait D. Shanafelt, Cristina Ivan, Masayoshi Shimizu, Kari G. Rabe, Nazila Nouraee, Mariko Ikuo, Asish K. Ghosh, Susan Lerner, Laura Z. Rassenti, Lianchun Xiao, Jianhua Hu, James M. Reuben, Steliana Calin, M. James You, John T. Manning, William G. Wierda, Zeev Estrov, Susan O’Brien, Thomas J. Kipps, Michael J. Keating, Neil E. Kay, George A. Calin
Journal: Blood
Blood (2013) 122 (11): 1891–1899.
https://doi.org/10.1182/blood-2013-01-478222
Published: 2013
Includes: Supplemental data
Journal Articles

Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia

Brief Report
Paolo Strati, Michael J. Keating, William G. Wierda, Xavier C. Badoux, Steliana Calin, James M. Reuben, Susan O’Brien, Steven M. Kornblau, Hagop M. Kantarjian, Hui Gao, Alessandra Ferrajoli
Journal: Blood
Blood (2013) 122 (5): 734–737.
https://doi.org/10.1182/blood-2013-04-495341
Published: 2013
Journal Articles

Long-Lasting Responses with Lenalidomide As Initial Therapy of Elderly Patients with Chronic Lymphocytic Leukemia (CLL)

Paolo Strati, Michael J. Keating, MD, William G. Wierda, MD, PhD, Xavier C. Badoux, MBBS, Steliana Calin, MD, James M. Reuben, PhD, Susan M. O'Brien, MD, Steven M. Kornblau, MD, Hagop M. Kantarjian, MD, Bang-Ning Lee, PhD, PA-C, Alessandra Ferrajoli, M.D.
Journal: Blood
Blood (2012) 120 (21): 3932.
https://doi.org/10.1182/blood.V120.21.3932.3932
Published: 2012
Journal Articles

Initial Experience with Lenalidomide As Consolidation Treatment in Patients with Chronic Lymphocytic Leukemia and Residual Disease After Chemotherapy,

Jenny V. Pozadzides, MD, Michael J Keating, MD, William G. Wierda, Susan O'Brien, MD, Jan A. Burger, MD, PhD, Jeffrey L. Jorgensen, MD, Steliana Calin, MD, SA Wang, MD, Susan Lerner, MS, BA, Alessandra Ferrajoli, MD
Journal: Blood
Blood (2011) 118 (21): 3907.
https://doi.org/10.1182/blood.V118.21.3907.3907
Published: 2011
Journal Articles

Combination Therapy with Ofatumumab and Lenalidomide in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): Results of a Phase II Trial

Alessandra Ferrajoli, MD, Susan O'Brien, MD, William G. Wierda, MD, PhD, Stefan Faderl, MD, Xavier Badoux, MD, Zeev Estrov, Ellen Schlette, MD, Susan C. Smith, BS, Ana B. Ayala, ADN, Lorenzo Falchi, MD, Steliana Calin, MD, Hagop M. Kantarjian, MD, Michael J Keating, MD
Journal: Blood
Blood (2011) 118 (21): 1788.
https://doi.org/10.1182/blood.V118.21.1788.1788
Published: 2011
Journal Articles

Aberrant Expression of Golgin-84 in Non-Hodgkin Lymphomas and Plasma Cell Myeloma

Ling Chen, Yaling Yang, PhD, C. Cameron Yin, MD, PhD, Gary Lu, MD, Su Chen, MD, PhD, Xiaoyan Huang, MD., MS, Jiayu Chen, PhD, Felix Chang, Effie Rahman, Steliana Calin, MD, L. Jeffrey Medeiros, MD, Roberto N. Miranda, MD, M. James You, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4633.
https://doi.org/10.1182/blood.V118.21.4633.4633
Published: 2011